How an emerging pharma is Identifying Market Opportunities with Location-based Analytics


An Emerging Bio-Pharma Company sought to identify untapped market opportunities and gain a competitive edge in the pharmaceutical industry. They faced the challenge of uncovering underserved regions with high disease prevalence where targeted campaigns could effectively establish their presence.



Anervea collaborated with the company to conduct an in-depth analysis using location-based analytics. By analysing market data and overlaying it with demographic and healthcare facility information, Anervea gained insights into regional disease prevalence, patient populations, and healthcare infrastructure. The objective was to identify unexplored market potential and strategically position the client's products in underserved areas.

Data Points

  • Market data sources, including custom acquired prescription records, disease prevalence statistics, and healthcare utilisation data.
  • Demographic information such as age, gender, income, and education level.
  • Healthcare facility data encompassing hospitals, clinics, and specialty centers.


Anervea's analysis revealed specific regions with high disease prevalence and limited healthcare solutions. Equipped with this valuable information, the client launched targeted campaigns, focusing on education, awareness, and product promotion in these underserved regions.


  • Captured a significant market share in the identified regions.
  • Achieved a remarkable 30% increase in sales.
  • Strengthened brand presence and customer loyalty.
  • Improved patient outcomes by addressing unmet medical needs.

By leveraging location intelligence, our client successfully launched targeted campaigns, leading to a 30% increase in sales and establishing their presence in previously underserved regions. Through these outcomes, Anervea's location-based analytics solution was vital in driving growth and market penetration for an emerging pharma company.

Recent Posts


The Indian pharmaceutical industry has been witnessing significant growth and advancements, and now it has set its sights


The landscape of medical treatments for obesity has been transformed by the advent of GLP-1-based weight loss drugs.


There are 81,000 pharmaceutical sales representative in the United States educating healthcare professionals (HCPs) about their drugs. They